Clinical Trial

LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy

Study acronym: LONGBOARD
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Prospective cohort of patients treated with trifluridine/tipiracil, maximal sample size 250 patients. It is expected, that 89 patients will experience a grade 3-4 neutropenia and will be included in the phase II.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2019-11-14; most recent amendment 2025-08-18.
Status change: Recruiting → Active, Not Recruiting 2024-03-08
Status change: Not Yet Recruiting → Recruiting 2020-07-09
Trial Details
NCT Number NCT04166604
Lead Sponsor GERCOR - Multidisciplinary Oncology Cooperative Group
Conditions Metastatic Colorectal Cancer
Enrollment 176 participants
Start Date 2020-05-20
Primary Completion 2023-11-10 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2025-08-19